Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
RLMD | US
-0.18
-5.50%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
13/09/2024
3.09
3.25
3.48
3.02
Relmada Therapeutics Inc. a clinical-stage biotechnology company focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone dextromethadone and REL-1017) a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder in adults. The company was founded in 2004 and is headquartered in Coral Gables Florida.
View LessLow Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Weakness based on declining price with high volume
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
118.6%1 month
101.3%3 months
110.4%6 months
91.0%-
-
1.16
-
-
0.54
-
-
-161.25M
79.92M
79.92M
-
-
-
-
-100.41
10.40
4.33
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
1.60
Range1M
1.60
Range3M
2.59
Rel. volume
1.25
Price X volume
505.21K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
INC Research Holdings Inc | INCR | Drug Manufacturers-Specialty & Generic | 1.98 | 81.09M | 0.51% | n/a | 41.98% |
Benitec Biopharma Limited | BNTC | Drug Manufacturers-Specialty & Generic | 8.15 | 80.20M | -0.12% | n/a | 3.08% |
Silver Spike Investment Corp. Common Stock | SSIC | Drug Manufacturers-Specialty & Generic | 11.38 | 70.73M | 0.00% | 12.73 | 0.00% |
DURECT Corporation | DRRX | Drug Manufacturers-Specialty & Generic | 1.51 | 49.72M | -1.95% | n/a | 318.92% |
Provectus Biopharmaceuticals Inc | PVCT | Drug Manufacturers-Specialty & Generic | 0.097 | 48.88M | -7.97% | n/a | 0.00% |
SCYNEXIS Inc | SCYX | Drug Manufacturers-Specialty & Generic | 1.46 | 48.08M | 8.96% | n/a | 25.73% |
Eagle Pharmaceuticals Inc | EGRX | Drug Manufacturers-Specialty & Generic | 4.31 | 46.18M | 12.53% | 5.00 | 27.85% |
Qilian International Holding Group Limited | QLI | Drug Manufacturers-Specialty & Generic | 6.48 | 35.96M | 3.02% | n/a | 1.35% |
BGXX | BGXX | Drug Manufacturers-Specialty & Generic | 0.1986 | 31.30M | -2.65% | n/a | 5.20% |
India Globalization Capital Inc | IGC | Drug Manufacturers-Specialty & Generic | 0.3563 | 26.45M | 0.06% | n/a | 4.33% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Culp Inc | CULP | Textile Manufacturing | 5.72 | 75.14M | -2.56% | n/a | 11.29% |
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 2.965 | 26.61M | -13.30% | n/a | 54.96% |
ILAG | ILAG | Building Products & Equipment | 1.1699 | 20.96M | -0.85% | n/a | 5.48% |
The Dixie Group Inc | DXYN | Textile Manufacturing | 0.7456 | 10.41M | 7.76% | n/a | 422.08% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.07 | 10.31M | 35.44% | n/a | 16.03% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.5337 | 4.94M | 18.60% | n/a | 19.98% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.31 | 3.62M | 1.55% | n/a | 9.62% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2475 | 3.40M | 15.12% | n/a | 0.97% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.7797 | 447.17K | -48.02% | n/a | 0.00% |
Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 14.21 | 0 | -0.28% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 0.54 | - | Cheaper |
Ent. to Revenue | - | - | - |
PE Ratio | - | 28.13 | - |
Price to Book | 1.16 | 11.07 | Cheaper |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 110.41 | - | Riskier |
Debt to Equity | - | -0.91 | - |
Debt to Assets | - | 0.45 | - |
Market Cap | 79.92M | - | Emerging |